Trials / Completed
CompletedNCT00430547
Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- Barwon Health · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether radioactive iodine, as compared to anti-thyroid medications, is a risk factor for the development or progression of thyroid-associated ophthalmopathy in patients with hyperthyroidism due to Graves' disease. The other aim of this study is to determine the incidence of the various ophthalmopathy subtypes and the utility of orbital antibodies in the diagnosis, classification and monitoring of patients with thyroid-associated ophthalmopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carbimazole, radio-active iodine (I131) |
Timeline
- Start date
- 2003-08-01
- Completion
- 2006-01-01
- First posted
- 2007-02-02
- Last updated
- 2007-02-02
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT00430547. Inclusion in this directory is not an endorsement.